Oncology Archives | Oncotarget.net

Oncotarget News

Agentic AI Systems May Transform Nutritional Care in Oncology

May 11, 2026

Cancer-related malnutrition affects up to 80% of patients and contributes to 10 to 20% of cancer deaths.”BUFFALO, NY - May 11, 2026 – A new editorial was published in Volume 17... read more

worried female doctor holding diagnosis and consulting upset senior woman with cancer in hospital

Oncotarget

Cancer Care in Conflict Zones Remains Critically Neglected

April 13, 2026

Cancer is an escalating yet neglected health crisis among refugees, migrants, and populations affected by conflict.”BUFFALO, NY - April 13, 2026 – A new review was published in Volume 17 of... read more

Oncotarget

Blocking Protein Control Pathway Slows Rhabdomyosarcoma Growth in Mice

August 29, 2025

Together, these findings confirm that proteostasis inhibition can slow RMS growth and suggest that targeting compensatory network components might yield synergistic outcomes.”BUFFALO, NY - August 29, 2025 – A new research... read more

Oncotarget

Balancing Time, Cost, and Quality in Cardio-Oncology Care

June 13, 2025

The unattainable triangle, also known as the iron triangle or triple constraint, traditionally applied in business as a model for balancing time, cost, and quality, offers valuable insight into the... read more

Oncotarget

Clear Scans Can Be Misleading: Residual Cancer Linked to Worse Outcomes

March 21, 2025

SABR is a well-established therapy in both the curative and metastatic setting, however, its ablative potential may not be as high as suggested by radiographic local control rates.”BUFFALO, NY -... read more

Oncotarget

Oncotarget to Participate at the AACR Annual Meeting 2025

March 17, 2025

Oncotarget is honored to participate in the American Association for Cancer Research (AACR) Annual Meeting 2025, scheduled for April 25-30 in Chicago.BUFFALO, NY - March 17, 2025 – Impact Journals (Oncotarget’... read more

Oncotarget

Pitfalls of FDA-Approved Germline Cancer Predisposition Tests

December 30, 2024

The FDA approval on September 29, 2023, for 'class III de novo' blood tests to assess hereditary cancer risk make widely available tests that may be obtained through a Direct... read more

Oncotarget

Artificial Intelligence: Revolutionizing Precision Oncology

August 27, 2024

Properly leveraged AI-based techniques could herald a new era of precision medicine guided by non-invasive, imaging-based disease evaluation."BUFFALO, NY- August 27, 2024 – A new editorial was published in Oncotarget's... read more

Figure 2: ShRNAs targeting KIAA0930 decrease KIAA0930 mRNA expression and suppress muscle atrophy in PANC-1 cells in vitro.

Oncotarget

KIAA0930: A Cachexic Phenotype Inducer in Cancer Cells

July 26, 2023

We believe that KIAA0930 would be a novel cachexia therapeutic target.”BUFFALO, NY- July 26, 2023 – A new research paper was published in Oncotarget's Volume 14 on July 20, 2023,... read more

Oncotarget

Oncotarget | New Oncology-Focused Papers Published in Volume 13

June 23, 2022

BUFFALO, NY- June 23, 2022 – At the start of 2022, Oncotarget began publishing research papers in a continuous publishing format in yearly volumes. As of June 23, 2022, Oncotarget has... read more